menu ☰
menu ˟

Interferon-free regimens advance in treatment of hepatitis C virus

20 Mar 2014
In December 2013, a new era dawned for patients with hepatitis C virus infection. That’s when the FDA granted approval for use of the nucleoside polymerase inhibitor sofosbuvir.Sofosbuvir (Sovaldi, Gilead Sciences) became the first oral drug to dem...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.